+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Latanoprost"

Ophthalmic Drugs Global Market Report 2024 - Product Thumbnail Image

Ophthalmic Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
From
Glaucoma Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Glaucoma Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
Glaucoma - Competitive Landscape, 2023 - Product Thumbnail Image

Glaucoma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
From
From
Glaucoma: Competitive Landscape to 2026 - Product Thumbnail Image

Glaucoma: Competitive Landscape to 2026

  • Report
  • December 2018
  • 48 Pages
  • Global
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Latanoprost is a medication used to treat glaucoma and ocular hypertension, two common optical disorders. It is a prostaglandin analog, meaning it works by increasing the outflow of fluid from the eye, reducing intraocular pressure. It is available as an eye drop, and is usually administered once daily. Common side effects include eye irritation, redness, and darkening of the eyelashes. Latanoprost is a widely used medication for the treatment of glaucoma and ocular hypertension. It is generally well tolerated and has been shown to be effective in reducing intraocular pressure. It is available in generic form, as well as under various brand names. In the Latanoprost market, there are several companies that produce and market the medication. These include Allergan, Pfizer, Sun Pharmaceuticals, and Merck. Show Less Read more